Related Experiment Video

Updated: Jun 23, 2026

Isolation of Atrial Myocytes from Adult Mice
08:34

Isolation of Atrial Myocytes from Adult Mice

Published on: July 25, 2019

Atrial natriuretic peptide and brain natriuretic peptide release in human essential hypertension

Hayet Soualmia1, Ilhem Ayadi, Souheil Omar

  • 1LR99ES11 Research Laboratory and Department of Biochemistry, Rabta Hospital, Tunis, Tunisia. hayetsoualmia@yahoo.fr

Clinical Laboratory
|May 26, 2009
PubMed

Insights

Hypertension elevates cardiac natriuretic peptides, atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP). This study suggests their increase is linked to blood pressure elevation, not left ventricular hypertrophy, to mitigate high blood pressure effects.

Area of Science:

  • Cardiology
  • Endocrinology
  • Hypertension Research

Background:

  • Hypertension is linked to altered vasoactive peptide levels, but the causes of these changes remain unclear.
  • Cardiac vasodilator hormones like atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) may play a role in managing blood pressure.
  • Understanding the relationship between natriuretic peptides and hypertension is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the plasma levels of cardiac vasodilator hormones (ANP, BNP) and vasoconstrictor hormones in hypertensive subjects.
  • To determine if elevated natriuretic peptides in hypertension are associated with blood pressure levels or left ventricular hypertrophy (LVH).
  • To explore the correlation between ANP, BNP, and systolic blood pressure in different subject groups.

Main Methods:

  • Measured plasma levels of ANP, BNP, renin, aldosterone, cortisol, and metanephrins in three groups: hypertensive (HT), healthy without family hypertension (NTFN), and healthy with family hypertension (NTFH).
  • Assessed left ventricular hypertrophy (LVH) using echocardiography in hypertensive patients.
  • Analyzed correlations between hormone levels, blood pressure, and echocardiographic findings.

Main Results:

  • Plasma ANP and BNP levels were significantly higher in hypertensive subjects compared to both healthy control groups (p<0.04).
  • No significant differences in ANP or BNP were found between the two healthy control groups (NTFN vs. NTFH).
  • Vasoconstrictor hormone levels did not differ significantly across the three groups. ANP levels correlated with systolic blood pressure in hypertensive individuals.

Conclusions:

  • Elevated natriuretic peptides (ANP and BNP) in hypertension appear to be a response to increased blood pressure rather than left ventricular hypertrophy.
  • These findings suggest a compensatory mechanism by natriuretic peptides to counteract the detrimental effects of high blood pressure.
  • Further research is warranted to elucidate the precise role of natriuretic peptides in the pathophysiology of hypertension.

More Related Videos

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors12:03

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

Published on: June 7, 2016

Novel Approach for Simultaneous Recording of Renal Sympathetic Nerve Activity and Blood Pressure with Intravenous Infusion in Conscious, Unrestrained Mice.11:08

Novel Approach for Simultaneous Recording of Renal Sympathetic Nerve Activity and Blood Pressure with Intravenous Infusion in Conscious, Unrestrained Mice.

Published on: February 14, 2018

Related Concept Videos

Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...